Boston Financial Mangement LLC Abbott Laboratories Transaction History

Boston Financial Mangement LLC

$3.18 Billion
Q4 2024

A detailed history of Boston Financial Mangement LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Boston Financial Mangement LLC holds 60,177 shares of ABT stock, worth $7.72 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

60,177

Previous 65,623 8.3%

Holding current value

$7.72 Million

Previous $7.48 Million 9.02%

% of portfolio

0.21%

Previous 0.23%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	SELL	$111.93 - $119.39 $609,570 - $650,197	-5,446 Reduced 8.3%	60,177 $6.81 Million
Q3 2024 Oct 24, 2024	BUY	$100.07 - $118.13 $53,137 - $62,727	531 Added 0.82%	65,623 $7.48 Million
Q2 2024 Jul 29, 2024	BUY	$100.73 - $112.44 $147,468 - $164,612	1,464 Added 2.3%	65,092 $6.76 Million
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $189,469 - $209,260	-1,730 Reduced 2.65%	63,628 $7.23 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $24,261 - $29,697	-269 Reduced 0.41%	65,358 $7.19 Million
Q3 2023 Nov 09, 2023	BUY	$95.53 - $114.62 $16,335 - $19,600	171 Added 0.26%	65,627 $6.36 Million
Q2 2023 Aug 07, 2023	SELL	$100.78 - $112.29 $166,186 - $185,166	-1,649 Reduced 2.46%	65,456 $7.14 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $480,328 - $565,375	-4,959 Reduced 6.88%	67,105 $6.8 Million
Q4 2022 Jan 27, 2023	BUY	$95.06 - $111.52 $222,725 - $261,291	2,343 Added 3.36%	72,064 $0
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $1.69 Million - $1.95 Million	17,446 Added 33.37%	69,721 $6.75 Million
Q2 2022 Aug 08, 2022	BUY	$102.07 - $123.37 $257,012 - $310,645	2,518 Added 5.06%	52,275 $5.68 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $202,613 - $247,074	1,777 Added 3.7%	49,757 $5.89 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $36,969 - $45,267	320 Added 0.67%	47,980 $6.75 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $320,815 - $354,915	-2,750 Reduced 5.46%	47,660 $5.63 Million
Q2 2021 Aug 03, 2021	SELL	$105.79 - $124.53 $167,994 - $197,753	-1,588 Reduced 3.05%	50,410 $5.84 Million
Q1 2021 May 07, 2021	SELL	$108.84 - $128.23 $109,275 - $128,742	-1,004 Reduced 1.89%	51,998 $6.23 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $232,575 - $253,440	-2,215 Reduced 4.01%	53,002 $5.8 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $186,212 - $226,141	-2,032 Reduced 3.55%	55,217 $6.01 Million
Q2 2020 Aug 10, 2020	BUY	$76.57 - $98.0 $580,400 - $742,840	7,580 Added 15.26%	57,249 $5.23 Million
Q1 2020 May 05, 2020	SELL	$62.82 - $91.86 $111,191 - $162,592	-1,770 Reduced 3.44%	49,669 $3.92 Million
Q4 2019 Feb 05, 2020	SELL	$78.51 - $87.4 $91,542 - $101,908	-1,166 Reduced 2.22%	51,439 $4.47 Million
Q3 2019 Nov 08, 2019	SELL	$81.84 - $88.74 $250,839 - $271,988	-3,065 Reduced 5.51%	52,605 $4.4 Million
Q2 2019 Jul 24, 2019	SELL	$72.88 - $85.0 $65,081 - $75,905	-893 Reduced 1.58%	55,670 $4.68 Million
Q1 2019 Apr 25, 2019	SELL	$66.22 - $80.06 $11,323 - $13,690	-171 Reduced 0.3%	56,563 $4.52 Million
Q4 2018 Jan 31, 2019	SELL	$65.56 - $74.27 $107,583 - $121,877	-1,641 Reduced 2.81%	56,734 $4.1 Million
Q3 2018 Nov 02, 2018	SELL	$60.81 - $73.36 $44,695 - $53,919	-735 Reduced 1.24%	58,375 $4.28 Million
Q2 2018 Aug 03, 2018	SELL	$57.57 - $63.54 $1.78 Million - $1.97 Million	-30,956 Reduced 34.37%	59,110 $3.61 Million
Q1 2018 Apr 25, 2018	SELL	$56.27 - $63.62 $86,093 - $97,338	-1,530 Reduced 1.67%	90,066 $5.4 Million
Q4 2017 Feb 05, 2018	SELL	$53.68 - $57.47 $11,916 - $12,758	-222 Reduced 0.24%	91,596 $5.23 Million
Q3 2017 Oct 30, 2017	BUY	$48.06 - $53.64 $4.41 Million - $4.93 Million	91,818	91,818 $4.9 Million

Others Institutions Holding ABT

# of Institutions

3,244

Shares Held

1.31B

Call Options Held

8.71M

Put Options Held

8.03M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $225B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Financial Mangement LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Financial Mangement LLC with notifications on news.

Account

Boston Financial Mangement LLC Abbott Laboratories Transaction History